Factor VIII and Factor IX

Table 2. HTC Population Profile Patient Characteristics, Factor VIII and Factor IX, Data Reported from 1/1/2012 through 9/29/2021

HTC Population Profile Patient Characteristics, Factor VIII and Factor IX
Hemophilia A (Factor VIII deficiency)(n=21844) Hemophilia B (Factor IX deficiency)(n=7036)
Factor level >=40% Mild Moderate Severe Severity
Unknown
Factor level >=40% Mild Moderate Severe Severity
Unknown
# (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%)
# of patients 1507 (100) 7059 (100) 3493 (100) 9348 (100) 437 (100) 599 (100) 2180 (100) 2424 (100) 1715 (100) 118 (100)
Age (years) <2 26 (2) 157 (2) 85 (2) 223 (2) 32 (7) 16 (3) 76 (3) 71 (3) 63 (4) * *
2-10 191 (13) 1070 (15) 607 (17) 1716 (18) 68 (16) 109 (18) 331 (15) 448 (18) 317 (18) 21 (18)
11-19 330 (22) 1600 (23) 737 (21) 1971 (21) 59 (14) 109 (18) 466 (21) 522 (22) 308 (18) 16 (14)
20-44 606 (40) 2294 (32) 1342 (38) 4188 (45) 177 (41) 259 (43) 684 (31) 782 (32) 689 (40) 37 (31)
45-64 236 (16) 1182 (17) 492 (14) 1006 (11) 70 (16) 70 (12) 393 (18) 381 (16) 258 (15) 22 (19)
65+ 118 (8) 756 (11) 230 (7) 244 (3) 31 (7) 36 (6) 230 (11) 220 (9) 80 (5) * *
Sex Male 250 (17) 5890 (83) 3431 (98) 9299 (99) 182 (42) 92 (15) 1653 (76) 2401 (99) 1709 (100) 66 (56)
Female 1257 (83) 1169 (17) 62 (2) 49 (1) 255 (58) 507 (85) 527 (24) 23 (1) 6 (0) 52 (44)
Ethnicity Hispanic, Latino/a, or Spanish origin 226 (15) 1420 (20) 743 (21) 1636 (18) 85 (19) 36 (6) 168 (8) 155 (6) 319 (19) 10 (8)
Not Hispanic, Latino/a, or Spanish origin 1222 (81) 5507 (78) 2704 (77) 7604 (81) 296 (68) 534 (89) 1966 (90) 2249 (93) 1372 (80) 92 (78)
Unknown 59 (4) 132 (2) 46 (1) 108 (1) 56 (13) 29 (5) 46 (2) 20 (1) 24 (1) 16 (14)
Race American Indian/Alaska Native 40 (3) 91 (1) 47 (1) 79 (1) 7 (2) * * * * 29 (1) 17 (1) * *
Asian 32 (2) 205 (3) 130 (4) 498 (5) 19 (4) * * 34 (2) 35 (1) 85 (5) * *
Black or African American 104 (7) 384 (5) 476 (14) 1440 (15) 40 (9) 30 (5) 170 (8) 101 (4) 252 (15) * *
Native Hawaiian or other Pacific Islander * * 11 (0) 11 (0) 51 (1) * * * * * * 9 (0) 8 (0) * *
White 1232 (82) 5966 (85) 2682 (77) 6868 (73) 292 (67) 523 (87) 1898 (87) 2199 (91) 1292 (75) 100 (85)
More than one of these * * 105 (1) 39 (1) 147 (2) * * * * 10 (0) 15 (1) 18 (1) * *
Unknown 83 (6) 297 (4) 108 (3) 265 (3) 72 (16) 33 (6) 58 (3) 36 (1) 43 (3) 10 (8)
Insurance Status Insured 1433 (95) 6738 (95) 3291 (94) 8906 (95) 365 (84) 448 (75) 1919 (88) 1891 (78) 1635 (95) 79 (67)
Uninsured 41 (3) 182 (3) 107 (3) 197 (2) 28 (6) 117 (20) 221 (10) 497 (21) 45 (3) 23 (19)
Unknown 33 (2) 139 (2) 95 (3) 245 (3) 44 (10) 34 (6) 40 (2) 36 (1) 35 (2) 16 (14)
History of HCV infection Yes 46 (3) 890 (13) 716 (20) 2297 (25) 31 (7) 7 (1) 208 (10) 399 (16) 520 (30) 10 (8)
No 1141 (76) 5410 (77) 2559 (73) 6593 (71) 250 (57) 416 (69) 1667 (76) 1746 (72) 1091 (64) 65 (55)
Unknown 320 (21) 759 (11) 218 (6) 458 (5) 156 (36) 176 (29) 305 (14) 279 (12) 104 (6) 43 (36)
History of HIV infection Yes 12 (1) 105 (1) 187 (5) 933 (10) 12 (3) * * 29 (1) 43 (2) 130 (8) * *
No 1181 (78) 6121 (87) 3060 (88) 7889 (84) 269 (62) 421 (70) 1828 (84) 2069 (85) 1463 (85) 70 (59)
Unknown 314 (21) 833 (12) 246 (7) 526 (6) 156 (36) * * 323 (15) 312 (13) 122 (7) * *

Note. Hemophilia severity is defined based on the level of factor activity circulating in the blood. In this table, “Factor level >=40%” is defined as greater than or equal to 40% baseline clotting factor activity; “mild” is defined as greater than 5% and less than 40% baseline clotting factor activity; “moderate” is defined as 1–5% baseline clotting factor activity; “severe” is defined as less than 1% baseline clotting factor activity; and “severity unknown” is reported if the factor activity is missing or unknown. Males and females with factor VIII and IX deficiency are classified the same.

On August 10, 2020, “intersex” was added as a response option. The number of intersex patients is too small to report by year or other characteristics; therefore, these counts have been excluded to protect patient confidentiality.

* Counts of five or fewer have been suppressed to protect patient confidentiality. Additional cells may be suppressed to prevent derivation of these counts by subtraction.